Halozyme’s common stock is publically traded on the Nasdaq Global Market under the symbol “HALO”.
No.
Halozyme does not pay a dividend on stock, and does not foresee doing so in the immediate future. Accordingly, Halozyme does not offer a DRIP (Dividend Reinvestment Program).
December 31.
Equiniti Group plc They can be reached at 303.282.4800 or https://equiniti.com/us/.
The transfer agent is responsible for maintaining all records of registered stockholders (include change of address, telephone number and name), canceling or issuing stock certificates and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name (i.e. by your broker), you must contact your broker for these services.
Contact Equiniti Group plc at 303.282.4800 or https://equiniti.com/us/. They can look up your records and make any necessary adjustment.
If your shares are held in your name, you may contact 303.282.4800 or https://equiniti.com/us/. If your shares are held in Street name (by your broker), you must contact your broker to update your address.
Halozyme Therapeutics 12390 El Camino Real San Diego, CA 92130 Phone: 858.794.8889 Fax: 858.704.8311 Email: ir@halozyme.com